Originally Posted by
Bjauck
The retail offer is for $150,000,000; The placement is for $1,000,000,000. So non-shareholders have the ability to take part in the much larger placement. Why not have a renounceable rights issue. Maybe a bit of extra cost, but more transparently fair for existing shareholders, especially for individual retail holders, who may not have the time, resources or stockbroker relationship to jump in on the placement - or rights.
I think the expansion of CDC is good investment, what with cloud data storage and AI growth.